Metabolomics analysis reveals aminoquinazolin derivative 9d-induced oxidative stress and cell cycle arrest in A549 cells

Abstract

A novel aminoquinazolin derivative (named 9d), synthesized in our lab shows potential antitumor activity against A549 lung cancer cell lines. However, previous studies on the pharmacological mechanism of 9d mostly focused on cell and gene levels; the metabolic mechanism remains unknown. In this paper, an ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS) based metabolomics approach was established to study the probable antitumor mechanism. Q-TOF MS and MS/MS were used to identify significantly different metabolites. 22 significantly different metabolites were observed between the 9d-treated A549 lung cells group and control group. They were involved in glycerophospholipid metabolism, glutathione metabolism, phenylalanine metabolism, cysteine and methionine metabolism, and aminoacyl-tRNA biosynthesis. The results showed that glutathione level and cell-membrane components phosphatidylcholines were decreased in 9d-treated cells, while their oxidative products, oxidized glutathione and lysophosphatidylcholines, were significantly increased. Further biological investigation showed an apparent accumulation of reactive oxygen species and a decrease in mitochondrial membrane potential.The results indicated that the aminoquinazolin derivative induced oxidative stress-mediated apoptosis.Moreover, phenylalanine metabolism suggested the up-regulation of L-phenylalanine might act as an endogenous drug carrier of 9d to improve cellular antiproliferation ability. The inhibition of aminoacyltransfer RNA and flow cytometry results indicated that cell cycle progression was blocked in the G1 phase, which was in accordance with the results obtained from some marketed aminoquinazolin derivatives. The above results proposed that 9d could induce oxidative stress and cell cycle arrest, which finally led to cell apoptosis in A549 cells. The study supplies a rapidly and highly active strategy to investigate the antitumor mechanism of drugs, which benefits its further improvement and development.

Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication

“…In non-infected cells, the cell cycle distribution in DMSO-treated A549 cells at 24 h.p.i was 73% in the G0/G1 phase, 10% in the S phase and 17% in the G2/M phase, as expected 31 , 32 . Treatment with SINE compounds significantly altered the distribution of cells in each phase of the cell cycle (Fig.…”

A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb

“…Hence, it was speculated that aminoacyl-tRNA biosynthesis was inhibited. Aminoacyl-tRNA biosynthesis is occurring at the G1 phase, as catalyzed by tRNA synthase [ 15 ]. When tRNA synthase is inhibited, the aminoacyl-tRNA biosynthesis is blocked and cells will arrest in the G1 phase.…”

Ultra-Performance Liquid Chromatography-Q-Exactive Orbitrap-Mass Spectrometry Analysis for Metabolic Communication between Heart and Kidney in Adriamycin-Induced Nephropathy Rats

“…Arginine is directly related to the production of nitric oxide in the body and participates in the regulation of end-stage renal degeneration [18-20]. In addition, the aminoacyl-tRNA biosynthesis pathway is related to oxidative stress, cell-cycle arrest, and apoptosis [21]. Besides arginine, several core differential metabolites are worth discussing.…”